Ethical oversight during COVID-19: rewriting the norms of research ethics review?

By Anna Chiumento and Lucy Frith One consequence of physical distancing in response to the COVID-19 pandemic has been the rapid suspension or adaptation of ongoing research activity.  This presents an opportunity for the research ethics community and researchers to promote ethical oversight that integrates the situated and informed judgement of researchers, rebalancing away from […]

Read More…

Is Research Ethics Committee review of most clinical trials fundamentally broken?

By Mark Yarborough Imagine that you suffered from a fatal neurodegenerative disorder like Alzheimers or ALS, or that you had a serious chronic condition like hypertension or heart disease. Imagine further that you were asked to participate in a clinical trial related to your disease. Finally, imagine that the person recruiting you into the trial […]

Read More…

We need a framework for the ethics of secondary epidemic vaccine trials

By Joshua Teperowski Monrad Introduction In the 21st century, few medical innovations have been as intensely anticipated as an effective vaccine for COVID-19. The pipeline of candidates now includes more than a hundred potential products, as governments, pharmaceutical companies, and researchers engage in an unprecedented effort to combat the worst pandemic of a century. This […]

Read More…

Experiment on identical siblings separated at birth: Ethical implications for researchers, universities and archives today

 By Adam Kelmenson, MS & Robert Klitzman, MD   The 2018 film Three Identical Strangers brought wide media and public attention to a previously little-known 1960’s psychological study.  The researchers had secretly separated several sets of twins and one set of triplets into adoptive families, and then studied them for decades without disclosing to the […]

Read More…

Risks, Benefits, and Taking Participants’ Values Seriously: The Case of HIV Cure Research

By Robert Steel The introduction and refinement of highly effective antiretroviral treatments has transformed HIV into a manageable chronic condition. Nonetheless, treatment is lifelong, burdening people living with HIV and health systems. So there is interest in a cure. But cure trials can be risky and the medical benefit of potentially being cured is limited […]

Read More…

Building bridges between the global south and north in research ethics

By Cory Goldstein, Tiwonge Mtande, and Charles Weijer. How does successful international collaboration in research ethics happen? We would like to share our experience. Tiwonge Mtande’s Perspective: I am a health researcher working at UNC-Project Malawi in Lilongwe, Malawi. In November 2017, while I was working on my Master’s degree, my supervisor, Prof. Doug Wassenaar, […]

Read More…